Histologic patterns of liver injury induced by anti-PD-1 therapy

BACKGROUND: Nivolumab and pembrolizumab—two monoclonal antibodies that block human programmed cell death-1 (PD-1)—have been successfully used to treat patients with multiple advanced malignancies. The histologic patterns of hepatic toxicity induced by anti-PD-1 treatment have not been well studied a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongwei, Hart, John, Ding, Xianzhong, Zhang, Xuchen, Feely, Michael, Yassan, Lindsay, Alpert, Lindsay, Soldevila-Pico, Consuelo, Zhang, Xuefeng, Liu, Xiuli, Lai, Jinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244961/
https://www.ncbi.nlm.nih.gov/pubmed/32467761
http://dx.doi.org/10.1093/gastro/goz044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244961/
https://www.ncbi.nlm.nih.gov/pubmed/32467761
http://dx.doi.org/10.1093/gastro/goz044

Ejemplares similares